FDA Holds Off on Salmon Decision

WASHINGTON The U.S. Food and Drug Administration last week ended three days of hearings without deciding whether Waltham, Mass.-based AquaBounty Technologies will be allowed to sell genetically modified salmon for human consumption. Instead, the agency has said it will file an Environmental Assessment of the salmon, which will be followed by a federally mandated 30-day public comment period. AquaBounty's

WASHINGTON — The U.S. Food and Drug Administration last week ended three days of hearings without deciding whether Waltham, Mass.-based AquaBounty Technologies will be allowed to sell genetically modified salmon for human consumption. Instead, the agency has said it will file an Environmental Assessment of the salmon, which will be followed by a federally mandated 30-day public comment period.

AquaBounty's salmon is an Atlantic salmon that has been modified with genes from Chin

Register to view the full article

Already a member? .